Cargando…
Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity
Peritoneal dialysis (PD) is an essential daily life-saving treatment for end-stage renal failure. PD therapy is limited by peritoneal inflammation, which leads to peritoneal membrane failure as a result of progressive fibrosis. Peritoneal infections, with the concomitant acute inflammatory response...
Autores principales: | Raby, Anne-Catherine, Labéta, Mario O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277495/ https://www.ncbi.nlm.nih.gov/pubmed/30538643 http://dx.doi.org/10.3389/fphys.2018.01692 |
Ejemplares similares
-
Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors
por: Colmont, Chantal S., et al.
Publicado: (2011) -
A review of research progress on mechanisms of peritoneal fibrosis related to peritoneal dialysis
por: Li, Jin’e, et al.
Publicado: (2023) -
Animal models in peritoneal dialysis
por: Nikitidou, Olga, et al.
Publicado: (2015) -
Aging of the Peritoneal Dialysis Membrane
por: Krediet, Raymond T.
Publicado: (2022) -
Corrigendum: Aging of the Peritoneal Dialysis Membrane
por: Krediet, Raymond T.
Publicado: (2022)